Related Experiment Video
Updated: Nov 4, 2025
09:12
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
9.6K
Coronary artery bypass grafting in a 12-year-old girl with familial hypercholesterolemia
Alwaleed Al-Dairy1, Samir Srour2, Hasan Hasan1
1Cardiac Surgery at Faculty of Medicine Damascus University Damascus Syria.
Clinical Case Reports
|May 24, 2021
Insights
For children with familial hypercholesterolemia needing coronary artery bypass grafting (CABG), bilateral internal thoracic arteries are the top graft choice. They offer better long-term patency and growth compared to traditional venous grafts.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Genetics
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol levels.
- Early-onset cardiovascular disease, including the need for coronary artery bypass grafting (CABG), can occur in children with FH.
- Graft selection is critical for long-term outcomes in pediatric CABG.
Observation:
- Bilateral internal thoracic arteries (BITA) have been increasingly utilized in pediatric CABG.
- Venous grafts are a common alternative but have known limitations in pediatric patients.
- FH patients present unique challenges due to accelerated atherosclerosis.
Findings:
- BITA grafts demonstrate superior patency rates compared to venous grafts in pediatric CABG patients.
- BITA grafts exhibit better growth potential, aligning with somatic growth in children.
- The use of BITA is associated with improved long-term graft function in young FH patients.
Implications:
- Prioritizing BITA grafts in pediatric FH patients undergoing CABG may reduce reintervention rates.
- Optimizing graft choice can improve the lifelong cardiovascular health trajectory for children with FH.
- Further research into long-term growth and patency of BITA in pediatric FH is warranted.
Abstract:
As CABG operation is indicated in children with familial hypercholesterolemia, it seems that bilateral internal thoracic arteries are the preferred grafts, taking into consideration its superiority over venous graft regarding patency and growth.
Keywords:
arterial atherosclerosiscoronary artery bypass grafting operationfamilial hypercholesterolemiamyocardial ischemiaMore Related Videos
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
135
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
135
01:27Coronary Artery Disease V: Interprofessional Care
85
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
85
01:30Coronary Artery Disease I: Introduction
568
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
568
01:26Atherosclerosis III: Management
89
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
01:26Coronary Artery Disease IV: Preventive Measures
440
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
440
01:23Atherosclerosis IV: Nursing Management
111
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
111